# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Ross Osborn reiterates Organogenesis Hldgs (NASDAQ:ORGO) with a Overweight and maintains $5 price ...
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.010 per share which met the analyst consensus estimate. Th...
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...